Eupraxia Pharmaceuticals Inc. (EPRX) income statement
EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.21−0.41 (-6.19%)
Close on Nov 18, 2026Market cap $374.43MP/E –Yield –
Eupraxia Pharmaceuticals Inc. income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -66.8%
Financial strength
- Current ratio
- 15.12
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1431.5%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 4.56
- Dividend yield
- –
See a number that looks wrong?